다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

XOMA

XOMA (XOMA)

XOMA Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:XOMA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	20:30	GlobeNewswire Inc.	XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	NASDAQ:XOMA	XOMA Corporation
2024/04/30	20:30	GlobeNewswire Inc.	XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	NASDAQ:XOMA	XOMA Corporation
2024/04/25	20:30	GlobeNewswire Inc.	XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMA	XOMA Corporation
2024/04/24	22:00	PR Newswire (US)	Actym Therapeutics Appoints Thomas Smart as CEO	NASDAQ:XOMA	XOMA Corporation
2024/04/03	22:00	GlobeNewswire Inc.	XOMA Corporation Announces Closing of Tender Offer	NASDAQ:XOMA	XOMA Corporation
2024/03/21	20:30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
2024/03/20	05:05	GlobeNewswire Inc.	XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	NASDAQ:XOMA	XOMA Corporation
2024/03/08	21:30	GlobeNewswire Inc.	XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMA	XOMA Corporation
2024/02/28	21:30	GlobeNewswire Inc.	XOMA to Present at Upcoming Investor Conferences in March	NASDAQ:XOMA	XOMA Corporation
2024/02/16	22:00	GlobeNewswire Inc.	XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right	NASDAQ:XOMA	XOMA Corporation
2024/01/18	22:30	GlobeNewswire Inc.	XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition	NASDAQ:XOMA	XOMA Corporation
2024/01/12	06:50	Dow Jones News	Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	NASDAQ:XOMA	XOMA Corporation
2024/01/12	06:05	GlobeNewswire Inc.	FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx	NASDAQ:XOMA	XOMA Corporation
2024/01/08	21:30	GlobeNewswire Inc.	XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors	NASDAQ:XOMA	XOMA Corporation
2024/01/02	21:30	GlobeNewswire Inc.	XOMA Announces Stock Repurchase Program of up to $50 Million	NASDAQ:XOMA	XOMA Corporation
2023/12/20	21:30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
2023/12/19	21:30	GlobeNewswire Inc.	XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties	NASDAQ:XOMA	XOMA Corporation
2023/11/07	21:30	GlobeNewswire Inc.	XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMA	XOMA Corporation
2023/10/31	20:30	GlobeNewswire Inc.	XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMA	XOMA Corporation
2023/09/25	20:30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
2023/09/06	20:30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:XOMA	XOMA Corporation
2023/08/08	20:30	GlobeNewswire Inc.	XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy	NASDAQ:XOMA	XOMA Corporation
2023/06/24	07:14	GlobeNewswire Inc.	XOMA Added to the Russell 2000® and Russell 3000® Indexes	NASDAQ:XOMA	XOMA Corporation
2023/06/22	20:30	GlobeNewswire Inc.	XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset	NASDAQ:XOMA	XOMA Corporation
2023/06/20	20:30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
2023/05/26	05:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
2023/05/23	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
2023/05/23	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
2023/05/20	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
2023/05/20	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation

검색 관련기사 보기:NASDAQ:XOMA

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

US Dollar vs Euro

Verizon Communications

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관